Medical School

  • University of Sherbrooke , 2013 , Sherbrooke, Quebec , Canada


  • CHU Sainte-Justine , 2014 , Montreal , Quebec, Canada


  • CHU Sainte-Justine , 2016 , Montreal, Quebec , Canada


  • Boston Children's Hospital , 2019 , Boston , MA


  • Boston Children's Hospital , 2020 , Boston , MA


  • American Board of Pediatrics, General Pediatrics


Publications powered by Harvard Catalyst Profiles

  1. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children Using Strain Analysis. CJC Open. 2021 Feb 25. View abstract
  2. Rapid ascending aorta stiffening in bicuspid aortic valve on serial cardiovascular magnetic resonance evaluation: comparison with connective tissue disorders. J Cardiovasc Magn Reson. 2021 02 22; 23(1):11. View abstract
  3. Socioeconomic and Racial and/or Ethnic Disparities in Multisystem Inflammatory Syndrome. Pediatrics. 2021 05; 147(5). View abstract
  4. The Electrocardiogram in Multisystem Inflammatory Syndrome in Children: Mind Your Ps and Qs. J Pediatr. 2021 Feb 02. View abstract
  5. Cardiac hemodynamics in fetuses with transposition of the great arteries and intact ventricular septum from diagnosis to end of pregnancy: longitudinal follow-up. Ultrasound Obstet Gynecol. 2021 Feb; 57(2):273-281. View abstract
  6. Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians. J Paediatr Child Health. 2020 Dec 09. View abstract
  7. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation. 2021 01 05; 143(1):78-88. View abstract
  8. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View abstract
  9. Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008848. View abstract
  10. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252. View abstract
  11. Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry. CJC Open. 2020 Nov; 2(6):632-640. View abstract
  12. Atrioventricular Block in Children With Multisystem Inflammatory Syndrome. Pediatrics. 2020 11; 146(5). View abstract
  13. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021 Feb; 180(2):307-322. View abstract
  14. Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Pacing Clin Electrophysiol. 2020 09; 43(9):901-907. View abstract
  15. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP). Pediatr Cardiol. 2020 Jun; 41(5):947-954. View abstract
  16. Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children. J Am Heart Assoc. 2020 02 18; 9(4):e012897. View abstract
  17. Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey. Int J Cardiol. 2020 05 15; 307:154-158. View abstract
  18. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92. View abstract
  19. Variation in the management of Kawasaki disease. Arch Dis Child. 2020 10; 105(10):1004-1006. View abstract
  20. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6). View abstract
  21. Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection. PLoS One. 2018; 13(10):e0206001. View abstract
  22. A Decade of NT-proBNP in Acute Kawasaki Disease, from Physiological Response to Clinical Relevance. Children (Basel). 2018 Oct 12; 5(10). View abstract
  23. Difference Between Persistent Aneurysm, Regressed Aneurysm, and Coronary Dilation in Kawasaki Disease: An Optical Coherence Tomography Study. Can J Cardiol. 2018 09; 34(9):1120-1128. View abstract
  24. Myocarditis and Kawasaki disease. Int J Rheum Dis. 2018 Jan; 21(1):45-49. View abstract
  25. Dynamic QT Interval Changes from Supine to Standing in Healthy Children. Can J Cardiol. 2018 01; 34(1):66-72. View abstract
  26. Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease. Pediatrics. 2017 Jun; 139(6). View abstract
  27. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease. Pediatr Int. 2017 Mar; 59(3):265-270. View abstract
  28. Importance of anatomical dominance in the evaluation of coronary dilatation in Kawasaki disease. Cardiol Young. 2017 Jul; 27(5):877-883. View abstract
  29. Fatal Kawasaki disease with incomplete criteria: Correlation between optical coherence tomography and pathology. Pediatr Int. 2015 Dec; 57(6):1174-8. View abstract
  30. Coronary Wall Structural Changes in Patients With Kawasaki Disease: New Insights From Optical Coherence Tomography (OCT). J Am Heart Assoc. 2015 May 19; 4(5). View abstract
  31. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease. Clin Endocrinol (Oxf). 2014 Feb; 80(2):296-300. View abstract